Literature DB >> 28268508

Extraction of medically interpretable features for classification of malignancy in breast thermography.

Himanshu Madhu, Siva Teja Kakileti, Krithika Venkataramani, Susmija Jabbireddy.   

Abstract

Thermography, with high-resolution cameras, is being re-investigated as a possible breast cancer screening imaging modality, as it does not have the harmful radiation effects of mammography. This paper focuses on automatic extraction of medically interpretable non-vascular thermal features. We design these features to differentiate malignancy from different non-malignancy conditions, including hormone sensitive tissues and certain benign conditions, which have an increased thermal response. These features increase the specificity for breast cancer screening, which had been a long known problem in thermographic screening, while retaining high sensitivity. These features are also agnostic to different cameras and resolutions (up to an extent). On a dataset of around 78 subjects with cancer and 187 subjects without cancer, that have some benign diseases and conditions with thermal responses, we are able to get around 99% specificity while having 100% sensitivity. This indicates a potential break-through in thermographic screening for breast cancer. This shows promise for undertaking a comparison to mammography with larger numbers of subjects with more data variations.

Entities:  

Mesh:

Year:  2016        PMID: 28268508     DOI: 10.1109/EMBC.2016.7590886

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  2 in total

1.  Automated vascular analysis of breast thermograms with interpretable features.

Authors:  Siva Teja Kakileti; Raghav Shrivastava; Geetha Manjunath; Mathukumalli Vidyasagar; Axel Graewingholt
Journal:  J Med Imaging (Bellingham)       Date:  2022-08-04

2.  Breast Cancer Identification via Thermography Image Segmentation with a Gradient Vector Flow and a Convolutional Neural Network.

Authors:  Santiago Tello-Mijares; Fomuy Woo; Francisco Flores
Journal:  J Healthc Eng       Date:  2019-11-03       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.